Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.
Advertisement
The Nutshell
Daily News Roundup
Most Recent
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
Researchers have found an increase in butterflies with unusual wing shapes, legs, and antennae than before the nuclear disaster.
The root system of a tree species is genetically different than the leaves of that individual, potentially modifying scientists’ understanding of evolution.
Researchers analyzing the bacteria in municipal drinking water find simple measures can increase beneficial bacteria while reducing pathogenic strains.
As many as 1,000 different non-native organisms used in the classroom are being released into the wild by school teachers.
A researcher from the John Wayne Cancer Institute has settled his scientific misconduct case with the Office of Research Integrity.
Australian trout are susceptible to skin cancer, according to a new study—the first evidence that wild fish can be afflicted by the disease.
Farmed salmon may have more in common with their more expensive wild-caught counterparts than consumers are led to believe.
An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
